Acadian Asset Management’s Champions Oncology CSBR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $121K | Sell |
21,323
-8,672
| -29% | -$55.1K | ﹤0.01% | 1704 |
|
|
2025
Q4 | $206K | Sell |
29,995
-6,187
| -17% | -$41.2K | ﹤0.01% | 1518 |
|
|
2025
Q3 | $232K | Hold |
36,182
| – | – | ﹤0.01% | 1373 |
|
|
2025
Q2 | $264K | Sell |
36,182
-3,329
| -8% | -$23.5K | ﹤0.01% | 1263 |
|
|
2025
Q1 | $341K | Buy |
39,511
+8,814
| +29% | +$89.3K | ﹤0.01% | 1154 |
|
|
2024
Q4 | $261K | Hold |
30,697
| – | – | ﹤0.01% | 1209 |
|
|
2024
Q3 | $148K | Hold |
30,697
| – | – | ﹤0.01% | 1471 |
|
|
2024
Q2 | $157K | Hold |
30,697
| – | – | ﹤0.01% | 1473 |
|
|
2024
Q1 | $148K | Hold |
30,697
| – | – | ﹤0.01% | 1227 |
|
|
2023
Q4 | $164K | Hold |
30,697
| – | – | ﹤0.01% | 1271 |
|
|
2023
Q3 | $190K | Hold |
30,697
| – | – | ﹤0.01% | 1198 |
|
|
2023
Q2 | $191K | Sell |
30,697
-779
| -2% | -$4.02K | ﹤0.01% | 1282 |
|
|
2023
Q1 | $124K | Hold |
31,476
| – | – | ﹤0.01% | 1350 |
|
|
2022
Q4 | $140K | Hold |
31,476
| – | – | ﹤0.01% | 1362 |
|
|
2022
Q3 | $234K | Hold |
31,476
| – | – | ﹤0.01% | 1179 |
|
|
2022
Q2 | $252K | Hold |
31,476
| – | – | ﹤0.01% | 1139 |
|
|
2022
Q1 | $255K | Hold |
31,476
| – | – | ﹤0.01% | 1155 |
|
|
2021
Q4 | $261K | Hold |
31,476
| – | – | ﹤0.01% | 1170 |
|
|
2021
Q3 | $320K | Sell |
31,476
-1
| -0% | -$10 | ﹤0.01% | 1168 |
|
|
2021
Q2 | $324K | Hold |
31,477
| – | – | ﹤0.01% | 1291 |
|
|
2021
Q1 | $356K | Buy |
31,477
+4,050
| +15% | +$47K | ﹤0.01% | 1308 |
|
|
2020
Q4 | $295K | Buy |
27,427
+2,143
| +8% | +$22.1K | ﹤0.01% | 1412 |
|
|
2020
Q3 | $233K | Buy |
25,284
+4,802
| +23% | +$42.8K | ﹤0.01% | 1396 |
|
|
2020
Q2 | $196K | Buy |
20,482
+2,184
| +12% | +$18.6K | ﹤0.01% | 1497 |
|
|
2020
Q1 | $135K | Hold |
18,298
| – | – | ﹤0.01% | 1287 |
|
|
2019
Q4 | $152K | Sell |
18,298
-33,580
| -65% | -$207K | ﹤0.01% | 1352 |
|
|
2019
Q3 | $293K | Sell |
51,878
-68,607
| -57% | -$445K | ﹤0.01% | 1225 |
|
|
2019
Q2 | $944K | Buy |
120,485
+1,265
| +1% | +$11.1K | ﹤0.01% | 816 |
|
|
2019
Q1 | $1.17M | Buy |
119,220
+12,047
| +11% | +$120K | 0.01% | 836 |
|
|
2018
Q4 | $836K | Buy |
107,173
+35,689
| +50% | +$410K | ﹤0.01% | 785 |
|
|
2018
Q3 | $1.25M | Buy |
+71,484
| New | +$637K | 0.01% | 670 |
|
|
2017
Q4 | – | Sell |
-978
| Closed | -$4K | – | 1592 |
|
|
2017
Q3 | $4K | Sell |
978
-4,438
| -82% | -$13.6K | ﹤0.01% | 1346 |
|
|
2017
Q2 | $14K | Hold |
5,416
| – | – | ﹤0.01% | 1289 |
|
|
2017
Q1 | $17K | Buy |
+5,416
| New | +$19K | ﹤0.01% | 1393 |
|
Other funds holding CSBR
BMC
NMC
TAM
VCM
MBAM
Acadian Asset Management's CSBR Position: Q1 2026 in Review
Acadian Asset Management reduced its Champions Oncology (CSBR) stake by 29% in Q1 2026, selling an estimated $55.1K and leaving 21,323 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #1704.
Acadian Asset Management first reported a position in CSBR in Q1 2017 and has held it in 34 quarters since. The position peaked at $1.25M in Q3 2018. 25 funds tracked by Wall St. Rank hold CSBR as of Q1 2026.
- Acadian Asset Management held 21,323 shares of Champions Oncology worth $121K as of Q1 2026.
- Acadian Asset Management sold 8,672 Champions Oncology shares in Q1 2026, an estimated $55.1K.
- Champions Oncology made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1704 holding.
- Acadian Asset Management first reported a position in Champions Oncology in Q1 2017 and has held it in 34 quarters since.
- Acadian Asset Management's Champions Oncology position peaked at $1.25M in Q3 2018.
- 25 funds tracked by Wall St. Rank held Champions Oncology as of Q1 2026.
Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.